Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

CNBCJuly 22, 2026 at 6:28 AM

The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers like India won't be easy.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

markets

Trump's push for American-made AI chips hits TSMC's margins

CNBCJuly 22, 2026 at 5:00 AM

markets

India steps up energy shift as costs and tariff pressures mount — oil blending push sparks backlash

CNBCJuly 22, 2026 at 4:56 AM

markets

I wanted to transfer $17,000 in credit-card debt. Why did Wells Fargo offer me only a $4,000 credit limit?

MarketWatchJuly 22, 2026 at 10:15 AM

← Back to all articles

Related Articles

Trump's push for American-made AI chips hits TSMC's margins

India steps up energy shift as costs and tariff pressures mount — oil blending push sparks backlash

I wanted to transfer $17,000 in credit-card debt. Why did Wells Fargo offer me only a $4,000 credit limit?